- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Apyx Medical (APYX)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 31.01 mm | 31.01 mm | 31.01 mm | 31.01 mm | 31.01 mm | 31.01 mm |
Cash burn (monthly) | 243.33 k | 522.58 k | 1.37 mm | 1.66 mm | 234.00 k | 1.03 mm |
Cash used (since last report) | 880.15 k | 1.89 mm | 4.97 mm | 6.00 mm | 846.39 k | 3.74 mm |
Cash remaining | 30.13 mm | 29.12 mm | 26.04 mm | 25.01 mm | 30.16 mm | 27.27 mm |
Runway (months of cash) | 123.8 | 55.7 | 18.9 | 15.1 | 128.9 | 26.4 |
13F holders | Current |
---|---|
Total holders | 43 |
Opened positions | 5 |
Closed positions | 9 |
Increased positions | 12 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 24.23 bn |
Total shares | 15.89 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Nantahala Capital Management | 3.17 mm | $5.01 bn |
Archon Capital Management | 3.14 mm | $4.96 bn |
Royce & Associates | 2.62 mm | $4.13 bn |
Vanguard | 1.48 mm | $2.33 bn |
Horizon Kinetics Asset Management | 615.00 k | $971.70 mm |
Silverberg Bernstein Capital Management | 571.23 k | $902.55 mm |
Taylor Frigon Capital Management | 545.75 k | $862.28 mm |
Commonwealth Equity Services | 527.06 k | $833.00 k |
BlackRock | 496.48 k | $784.43 mm |
Geode Capital Management | 352.81 k | $557.59 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 May 25 | Vizirgianakis Stavros G. | Stock Option (Option to Buy) Common Stock | Grant | Acquire A | No | No | 1.48 | 128,000 | 189.44 k | 128,000 |
15 May 25 | Goodwin Charles D. II | Stock Option (Option to Buy) Common Stock | Grant | Acquire A | No | No | 1.48 | 193,000 | 285.64 k | 193,000 |
15 May 25 | Wendy Lauren Levine | Stock Option (Option to Buy) Common Stock | Grant | Acquire A | No | No | 1.48 | 64,000 | 94.72 k | 64,000 |
15 May 25 | Matthew C Hill | Stock Option (Option to Buy) Common Stock | Grant | Acquire A | No | No | 1.48 | 100,000 | 148.00 k | 100,000 |
15 May 25 | Moshe Citronowicz | Stock Option (Option to Buy) Common Stock | Grant | Acquire A | No | No | 1.48 | 36,000 | 53.28 k | 36,000 |